Obesity exacerbates many causes of death, but risks are different for men and women

People who carry around unhealthy amounts of weight don't just have heart disease and diabetes to worry about. Obesity is implicated in two thirds of the leading causes of death from non-communicable diseases worldwide and the risk of certain diseases differs for men and women.

Read more

Artificial pancreas system better controls blood glucose levels than current technology

A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.

Read more

Scientists identify new signposts in blood and urine to reflect what we eat and drink

Researchers have identified several chemical signatures, detectable in blood and urine, that can accurately measure dietary intake, potentially offering a new tool for physicians, dieticians and researchers to assess eating habits, measure the value of fad diets and develop health policies.

Read more

Deleting a liver enzyme lowers the health risk of sweet treats (at least in mice)

Hepatic insulin resistance, caused by diets high in sugar and fat, can lead to type 2 diabetes. Researchers found that the Elovl6 gene plays a key role in hepatic insulin resistance. Deleting Elov6 in liver cells causes a rise in a specific ceramide lipid that protects mice from hepatic insulin resistance due to excessive dietary sugar. The findings could help efforts to find a targeted treatment for the condition.

Read more

Study looks at distribution of new cases of diabetes, density of specialists

Researchers analyzed national data on the prevalence of diabetes and the number of internal medicine specialists in each U.S. state. They found that cardiologists were the highest represented specialists and conclude that they are well positioned to be integral members of a patient's care team.

Read more

Metformin offers no strength training benefits for seniors, study shows

A clinical trial argues against the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass. The double-blind trial found that older adults who took metformin while performing rigorous resistance exercise training had smaller gains in muscle mass than the placebo group.

Read more

Resistance to last resort drug arose in patient over 3 weeks

French investigators have described development of resistance to one of the last resort therapies used to treat extremely drug-resistant Pseudomonas aeruginosa. That resistance arose in a single patient over a scant 22 days. They subsequently identified the single nucleotide mutation in P. aeruginosa that caused the resistance.

Read more